Chaoshu Tang Selected Research

Postural Orthostatic Tachycardia Syndrome

1/2021	Baseline Corrected QT Interval Dispersion Is Useful to Predict Effectiveness of Metoprolol on Pediatric Postural Tachycardia Syndrome.
1/2019	Heart Rate Variability Predicts Therapeutic Response to Metoprolol in Children With Postural Tachycardia Syndrome.
1/2018	Plasma Homocysteine Level in Children With Postural Tachycardia Syndrome.
12/2017	Serum Resistin Negatively Correlates with Clinical Severity of Postural Tachycardia Syndrome in Children.
10/2016	Body Mass Index (BMI) is Associated with the Therapeutic Response to Oral Rehydration Solution in Children with Postural Tachycardia Syndrome.
6/2015	Total peripheral vascular resistance, cardiac output, and plasma C-type natriuretic Peptide level in children with postural tachycardia syndrome.
1/2015	[Evaluation of the changes in heart rate during head-up test predicting the efficacy of oral rehydration salts on postural tachycardia syndrome in children].
1/2015	Plasma C-type natriuretic peptide as a predictor for therapeutic response to metoprolol in children with postural tachycardia syndrome.
8/2014	Usefulness of plasma copeptin as a biomarker to predict the therapeutic effectiveness of metoprolol for postural tachycardia syndrome in children.
8/2014	Plasma copeptin and therapeutic effectiveness of midodrine hydrochloride on postural tachycardia syndrome in children.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chaoshu Tang Research Topics

Disease

18	Postural Orthostatic Tachycardia Syndrome 01/2021 - 01/2011
15	Inflammation (Inflammations) 01/2022 - 08/2008
15	Hypertension (High Blood Pressure) 01/2022 - 02/2003
11	Atherosclerosis 01/2022 - 11/2006
11	Pulmonary Hypertension 01/2022 - 09/2002
10	Vascular Remodeling 11/2021 - 09/2002
9	Cardiovascular Diseases (Cardiovascular Disease) 09/2022 - 05/2004
7	Vascular Calcification 01/2022 - 01/2003
7	Ischemia 11/2020 - 02/2004
6	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021 - 05/2007
6	Vasovagal Syncope 01/2019 - 04/2008
5	Hypertrophy 01/2022 - 01/2002
5	Insulin Resistance 01/2021 - 04/2008
5	Hypoxia (Hypoxemia) 01/2021 - 01/2002
5	Body Weight (Weight, Body) 10/2018 - 10/2008
4	Acute Lung Injury 01/2022 - 09/2008
4	Atherosclerotic Plaque (Atheroma) 10/2019 - 02/2009
4	Reperfusion Injury 02/2010 - 02/2004
3	Sepsis (Septicemia) 01/2022 - 05/2002
3	Fibrosis (Cirrhosis) 01/2022 - 07/2009
3	Abdominal Aortic Aneurysm 01/2021 - 12/2012
3	Hyperhomocysteinemia 05/2010 - 12/2003
2	Diabetes Mellitus 01/2021 - 03/2007
2	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2019 - 10/2015
2	Obesity 10/2018 - 06/2013
2	Heart Failure 10/2011 - 02/2010
2	Myocardial Infarction 02/2010 - 08/2008
2	Syncope (Fainting) 07/2009 - 04/2008
2	Hypotension (Low Blood Pressure) 11/2004 - 07/2003
2	Hyperplasia 06/2004 - 03/2003
2	Shock 08/2003 - 07/2003
2	Septic Shock (Toxic Shock Syndrome) 08/2003 - 07/2003
1	Colitis 01/2022

Drug/Important Bio-Agent (IBA)

30	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 09/2022 - 08/2003
13	Sulfur DioxideIBA 11/2021 - 02/2009
9	Peptides (Polypeptides)IBA 07/2013 - 03/2003
8	Angiotensin IIIBA 01/2021 - 03/2003
8	Metoprolol (Toprol-XL)FDA LinkGeneric 01/2021 - 04/2008
8	sodium bisulfide (NaHS)IBA 10/2019 - 02/2003
6	CollagenIBA 10/2016 - 09/2002
6	Midodrine (Midon)FDA LinkGeneric 08/2014 - 01/2011
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2009
5	urotensin IIIBA 07/2013 - 01/2002
5	GhrelinIBA 10/2011 - 07/2003
4	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022 - 02/2015
4	MonocrotalineIBA 01/2022 - 10/2016
4	EnzymesIBA 11/2020 - 10/2003
4	LipidsIBA 10/2019 - 10/2008
4	Apolipoproteins E (ApoE)IBA 10/2019 - 02/2009
4	SaltsIBA 01/2017 - 08/2012
4	Messenger RNA (mRNA)IBA 06/2013 - 05/2003
4	AdrenomedullinIBA 07/2012 - 03/2003
3	GasotransmittersIBA 01/2022 - 02/2015
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2021 - 01/2002
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 04/2014
3	chromogranin A (344-364)IBA 11/2020 - 08/2013
3	CystathionineIBA 11/2020 - 01/2017
3	Adenosine Triphosphate (ATP)IBA 01/2018 - 02/2004
3	CalciumIBA 01/2018 - 05/2007
3	HomocysteineIBA 01/2018 - 12/2003
3	ResistinIBA 12/2017 - 04/2008
3	Oleic Acid (Oleate)IBA 11/2017 - 09/2008
3	Carbon MonoxideIBA 01/2017 - 01/2003
3	SolutionsIBA 10/2016 - 10/2003
3	Cholecalciferol (Vitamin D3)FDA Link 02/2016 - 01/2003
3	Nicotine FDA Link 02/2016 - 01/2003
3	C-Type Natriuretic Peptide (Peptide, C-Type Natriuretic)IBA 06/2015 - 07/2003
3	oxidized low density lipoproteinIBA 04/2014 - 06/2010
3	ApolipoproteinsIBA 02/2014 - 10/2012
3	Cystathionine gamma-Lyase (Cysteine Desulfhydrase)IBA 07/2009 - 01/2004
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2022
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2021 - 03/2003
2	Insulin (Novolin)FDA Link 01/2021 - 01/2013
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2013
2	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 11/2020 - 11/2015
2	Protein Kinases (Protein Kinase)IBA 11/2020 - 11/2013
2	LyasesIBA 11/2020 - 10/2019
2	AntioxidantsIBA 10/2020 - 01/2017
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 09/2008
2	Cysteine (L-Cysteine)FDA Link 10/2019 - 04/2014
2	GYY 4137IBA 10/2019 - 01/2013
2	Blood Glucose (Blood Sugar)IBA 10/2018 - 01/2014
2	Biological ProductsIBA 01/2017 - 02/2003
2	ORALIT (ORS)IBA 10/2016 - 01/2015
2	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2016 - 05/2002
2	Biomarkers (Surrogate Marker)IBA 10/2015 - 08/2014
2	salicylhydroxamic acid (SHAM)IBA 07/2014 - 05/2007
2	Calcitonin Gene-Related PeptideIBA 02/2014 - 03/2003
2	Atrial Natriuretic Factor (ANF)IBA 01/2014 - 01/2013
2	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2011 - 07/2009
2	propargylglycineIBA 06/2008 - 01/2004
2	NF-kappa B (NF-kB)IBA 04/2008 - 11/2006
2	Taurine FDA Link 05/2004 - 05/2003
2	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 12/2003 - 01/2003
2	EndotoxinsIBA 08/2003 - 07/2003
2	Arginine (L-Arginine)FDA Link 09/2002 - 01/2002

Therapy/Procedure

4	Therapeutics 01/2022 - 04/2008
3	Ligation 08/2007 - 05/2002
3	Punctures 08/2007 - 05/2002
2	Fluid Therapy (Oral Rehydration Therapy) 10/2016 - 01/2015